Cargando…
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial
BACKGROUND: The impact of baseline anemia in a contemporary acute coronary syndrome (ACS) population undergoing percutaneous coronary intervention in the era of predominant radial artery access, potent P2Y12 inhibition, and rare use of glycoprotein IIb/IIIa inhibitors has not been adequately studied...
Autores principales: | Wester, Axel, Attar, Rubina, Mohammad, Moman Aladdin, Andell, Pontus, Hofmann, Robin, Jensen, Jens, Szummer, Karolina, Erlinge, David, Koul, Sasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759912/ https://www.ncbi.nlm.nih.gov/pubmed/31387441 http://dx.doi.org/10.1161/JAHA.119.012741 |
Ejemplares similares
-
Peripheral artery disease and outcomes in patients with acute myocardial infarction
por: Attar, Rubina, et al.
Publicado: (2019) -
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020) -
Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
por: Wester, Axel, et al.
Publicado: (2021) -
Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction
por: Entezarjou, Artin, et al.
Publicado: (2018) -
Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy
por: Bergman, Sofia, et al.
Publicado: (2021)